Robinson Esalimba

Robinson Esalimba

Special Report: IP Protection Secondary To Support For Small African Innovators

Systematic and sustained programmes aimed at identifying and supporting African innovative talent may be a key part of Africa’s technological evolution, according to researchers and young entrepreneurs interviewed by Intellectual Property Watch. In the second part of a two-part series highlighting innovation challenges in Africa, Intellectual Property Watch focuses on harnessing and nurturing African innovation talent.

US Groups Duel Over Access To ACTA Negotiation

During the most recent negotiations on the Anti-Counterfeiting Trade Agreement (ACTA) in Seoul, Korea on 4-6 November, about which no information is available, US industry and public interest groups issued statements taking widely divergent positions on progress of the talks.

Spurring Local Innovation In Africa By Improving Access To Information

Greater awareness of the existence of open access information resources for innovation and making the information easily accessible and relevant to developing country users could help spur innovation in these countries, according to top technical assistance providers and local innovators.

Novartis Persists In Challenge To Indian Patent Law; India Rejects More AIDS Drugs Patents

Undeterred by two previous decisions by Indian authorities holding that under Indian Patent Law, its leukaemia drug - Gleevec is not patentable, Novartis now wants to take the fight to the Indian Supreme Court. Meanwhile, also this week, sources say Indian authorities rejected applications for patents on two HIV/AIDS drugs, opening the way for cheaper generic versions to be developed and marketed.